Drug Database
Back to search

Netherlands· NL-78334882e23e

Carglumaatzuur Tillomed 200 mg dispergeerbare tabletten

A carglumic acid product containing cargluminezuur, registered in Netherlands by Tillomed Pharma GmbH. The same ATC class is registered in 16 of our 19 countries.

ATC A16AA05

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedCarglumaatzuur Tillomed 200 mg disper…ATCA16AA05REGISTER NO.NL-78334882e23ePACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cargluminezuurAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Carglumic acid is registered in 16 of 19 countries.

Countries holding a registration under ATC A16AA05 (carglumic acid), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose
Search carglumic acid products by name

Carglumic acid · ATC A16AA05

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of carglumic acid costs, country by country.

Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Carglumic acid · price per daily dose (0.2 g)

USD · FX 28 Sept 2026

  • IT Italy$92.77
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CARGLUMINEZUUR
Manufacturer
Tillomed Pharma GmbH
Country
Netherlands (NL)
ATC code
A16AA05
ATC class
Carglumic acid
Defined daily dose
0.2 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    129043

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Carglumic acid in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All carglumic acid products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Austria · Carglumsäure Waymade
  • Czechia · Carglumic Acid
  • Germany · Carglumsäure Waymade, Carglumsäure Zentiva
  • Denmark · Cargluminsyre
  • Spain · Ácido Carglúmico, Ácido Carglúmico Tillomed
  • Finland · Karglumiinihappo Waymade
  • France · Acide Carglumique Tillomed, Acide Carglumique Waymade
  • United Kingdom (Northern Ireland) · Carglumic Acid Waymade
  • Greece · Carglumic Acid, Carglumic Acid Tillomed
  • Iceland · Carbaglu, Ucedane
  • Italy · Acido Carglumico Waymade
  • Liechtenstein · Carbaglu, Ucedane
  • Norway · Carbaglu, Kargluminsyre Waymade
  • Poland · Kwas Kargluminowy
  • Portugal · Ácido Carglúmico, Ácido Carglúmico Waymade
  • Sweden · Kargluminsyra Waymade

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ebbcd451-2fdb-442d-a1b7-b163bc36f319
GET /v1/drugs/ebbcd451-2fdb-442d-a1b7-b163bc36f319?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Dispergeerbare tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h129043_smpc.pdf",
  "strength": null,
  "atc_label": "Carglumic Acid",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg129043",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "NATRIUMLAURILSULFAAT",
    "NATRIUMSTEARYLFUMARAAT",
    "SILICIUMDIOXIDE (E 551)"
  ],
  "substances": [
    "CARGLUMINEZUUR"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h129043.pdf",
  "authorised_at": "2023/03/28",
  "procedure_number": "DE/H/7265/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "129043",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about carglumic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console